세계의 유전자 융합 검사(Gene Fusion Testing) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 기술 동향, 시장 규모 추이 및 예측, 각종 부문별/지역별 상세 분석, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
시장 전망
조사 범위
시장 요약
개요
현재의 시장 시나리오
부문 분석
기술 진보
결론
제2장 시장 개요
개요
Porter의 Five Forces 분석
거시경제 요인 분석
의료비 지출
고령화 사회
미국 관세 시나리오
제3장 시장 역학
시장 역학
시장 성장 촉진요인
암 발생률 증가
맞춤형 의료 도입 확대
시장 성장 억제요인
첨단시험 방법 고비용성
유전자 융합 검사 복잡한 상환 범위
시장 기회
신흥 시장
암 인지도 향상과 조기 발견 프로그램
시장이 해결해야 할 과제
숙련 한 전문가 부족
제4장 신기술과 개발
신기술
단일 분자 롱 리드 시퀀싱
CRISPR 기반 융합 감지
디지털 PCR(dPCR) 및 멀티플렉스 qPCR 어세이
AI
제5장 시장 세분화 분석
세분화 내역
시장 분석 : 기술별
중요 포인트
차세대 시퀀싱(NGS)
중합효소 연쇄반응(PCR)
Fluorescence in Situ Hybridization (FISH)
면역조직화학(IHC)
시장 분석 : 적응증별
중요 포인트
고형 종양
혈액암
시장 분석 : 최종사용자별
중요 포인트
제약 및 바이오테크놀러지 기업
병원 및 진단실험실
학술 연구센터
분석 지역
시장 분석 : 지역별
중요 포인트
북미
유럽
아시아태평양
중동 및 아프리카
남미
제6장 경쟁 정보
중요 포인트
경쟁 구도
주요 기업
주요 전개·전략
제7장 부록
조사 방법
출전
약어
기업 개요
AMOY DIAGNOSTICS CO. LTD.
BIOCARE MEDICAL LLC.
BIOCARTIS
F. HOFFMANN-LA ROCHE LTD.
GUARDANT HEALTH INC.
ILLUMINA INC.
INTEGRATED DNA TECHNOLOGIES INC.
MYRIAD GENETICS INC.
QIAGEN
THERMO FISHER SCIENTIFIC INC.
신흥 스타트업 기업/시장 디스럽터
LSH
영문 목차
영문목차
This report provides detailed information on the global gene fusion testing market. It highlights current and future market trends, as well as a comprehensive competitive landscape. The report analyzes market trends with data from 2024, estimates from 2025, and projections of compound annual growth rates (CAGRs) through 2030.
Report Scope
The report provides an overview of the gene fusion testing market and analyzes market trends. It includes global revenue ($ million) using 2024 as the base year, estimated data for 2025 and projected data for 2026 through 2030.
The market is segmented by technology, indication and end user. By technology, the market is segmented into fluorescence in situ hybridization (FISH), next-generation sequencing (NGS), polymerase chain reaction (PCR) and immunohistochemistry (IHC). By indication, it is segmented into hematological cancer and solid tumor. By end user, the market comprises pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, as well as academic and research centers. Geographical regions covered in this study are North America, Europe, Asia-Pacific, the Middle East and Africa (MEA), and South America.
The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It also discusses emerging technologies related to the market.
The report concludes by analyzing the competitive landscape and providing the leading gene fusion testing companies. It also contains a dedicated section of company profiles that covers details such as overview, key financials, product portfolio and recent developments in major companies.
Report Includes
Overview and an analysis of the global market for gene fusion testing technologies
Analyses of the global market trends, with historic revenue (sales data) from 2022 to 2024, estimates for 2025 and projections of CAGRs through 2030
Understanding of the technology background for fusion genes, their applications in cancer research and long-read transcriptome sequencing data
Estimates of the current market size and revenue prospects, along with a corresponding market share analysis based on the technology type, disease indication, end user and region
Facts and figures pertaining to the global market dynamics, opportunities and deterrents, technological advancements, regulations, prospects and the impact of macroeconomic factors
Insights derived from Porter's Five Forces model, as well as global supply chain analyses
Patent review, featuring key granted and published patents
Analysis of the industry structure, including companies' market shares and rankings, product mappings, strategic initiatives, M&A activity and a venture funding outlook
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
Profiles of the leading companies in the market
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Technological Advances
Conclusion
Chapter 2 Market Overview
Overview
Porter's Five Forces Analysis
Potential for New Entrants (Moderate)
Bargaining Power of Suppliers (Moderate to High)
Bargaining Power of Buyers (High)
Threat of Substitutes (Low)
Competition in the Industry (High)
Macroeconomic Factors Analysis
Healthcare Spending
Aging Population
U.S. Tariff Scenario
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Incidence of Cancer
Rising Adoption of Personalized Medicine
Market Restraints
High Cost of Advanced Testing Method
Complex Reimbursement Coverage of Gene Fusion Testing
Market Opportunities
Emerging Markets
Increasing Awareness and Early Cancer Detection Programs
